Keep a written log of all medications and their administration times to share with both your weight loss prescriber and infectious disease specialist
As of July 2026, the FDA has not required Novo Nordisk to add a NAION warning to Wegovys label
Backed by extensive clinical trials, both have received FDA-approved status and are changing the way we manage weight-related chronic conditions, including elevated blood sugar levels, blood pressure, and cholesterol
Take it regularly at the same time each day
However, with the progression of research, it has become evident that GLP-1R is broadly distributed across various organs and tissues, including but not limited to the brain, heart, kidneys, intestines, eyes, and the vascular system (Meier, 2012